DermTech, Inc. Quarterly Nonoperating Income (Expense) in USD from Q3 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
DermTech, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2018 to Q1 2024.
  • DermTech, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was $498K, a 35.7% decline year-over-year.
  • DermTech, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was $2.57M, a 18.4% increase year-over-year.
  • DermTech, Inc. annual Nonoperating Income (Expense) for 2023 was $2.85M, a 92.4% increase from 2022.
  • DermTech, Inc. annual Nonoperating Income (Expense) for 2022 was $1.48M.
  • DermTech, Inc. annual Nonoperating Income (Expense) for 2021 was -$937K, a 21.1% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $2.57M $498K -$277K -35.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $2.85M $661K +$5K +0.76% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $2.85M $646K +$157K +32.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $2.69M $769K +$515K +203% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $2.17M $775K +$692K +834% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $1.48M $656K +$350K +114% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $1.13M $489K +$282K +136% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $850K $254K +$49K +23.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $801K $83K +$1.74M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$937K $306K +$1.54M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 -$2.48M $207K +$91K +78.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$2.57M $205K +$375K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$2.95M -$1.66M -$1.76M -1691% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 -$1.19M -$1.24M -$797K -181% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 -$391K $116K -$317K -73.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$74K -$170K +$194K +53.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 -$268K $104K +$2.26M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$2.53M -$441K Oct 1, 2019 Dec 31, 2019 10-K 2022-03-10
Q3 2019 $433K +$533K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$364K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 -$2.15M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q3 2018 -$100K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.